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C H A P T E R 1 
GENERAL INTRODUCTION AND PROBLEM STATEMENT 
The relation between experimental and clinical transplan-
tation has two aspects. On the one hand, the development of 
current clinical transplantation has evidently resulted from 
findings obtained in animal experiments; on the other hand, it 
is precisely in the clinical setting that the problems posed 
by tissue transplantation have regained topical interest, and 
have given a fresh impetus to experimental research on the 
transplantation reaction. However, the situations which arise 
in clinical organ transplantations are so complex, and so dif-
ficult to reproduce, that new approaches to improved therapy 
can be explored only in animal experiments, in which an attempt 
can be made to reduce them to their component parts, and measure 
them in a reproducible way. 
Our knowledge of the transplantation phenomena largely 
originates from experimental research on malignant tumours in 
mice. It has long been known that a tumour which has either 
occurred spontaneously or has been induced by means of carcino-
genic substances, is usually rejected 10-12 days after its 
transplantation into a non-syngeneic host. This rejection is 
based on the recognition, by the host, of the histocompatibility 
antigens present in the tumour (Gorer 1937). These histocompati-
bility or transplantation antigens can be defined as genetically 
determined factors present in a transplant, which - if not present 
in the host - evoke an immunological response that can lead to 
rejection of the transplanted tissue. Normal tissues are rejected 
by the same mechanisms as malignant tumours. 
In most cases the contact with foreign tissue results in a 
dual reaction. A cell mediated immune response occurs, which 
shows the characteristics of a delayed hypersensitivity reac-
tion. As well a humoral response occurs with the synthesis of 
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circulating antiboaies. Our understanding of the interrelation 
between these two responses is still limited. It is beyond 
doubt, however, that both mechanisms can play an important 
role in the rejection of foreign tissue. 
In the cellular inmune response, specifically activated 
lymphocytes are formed: so-called "killer"cells which migrate 
to the graft and cause destruction of its cells. This cyto-
lytic action may be effected through cell-bound antibodies 
localized on the external surface of the lymphocytes (Amos 
and Koprowsky 1963). 
The humoral response likewise plays a role in the trans-
plantation reaction. With reference to a recent survey of the 
relevant literature (Winn 1970), we may confine ourselves to 
the statement that the action of humoral antibodies in vivo 
can be widely diverse. Experimental and clinical experience 
has shown that the presence of circulating antibodies against 
histocompatibility antigens of a graft, for example, a human 
kidney allograft, can lead to hyperacute rejection. It is also 
highly probable that humoral antibodies can play a role of 
importance in chronic graft rejection. We find a counterpart 
of this in a phenomenon known as immunological enhancement, 
which can be defined as prolonged survival of a graft in the 
presence of antibodies directed against transplantation anti-
gens of the graft (Kaliss 1969). Specific antibodies can be 
passively administered to the recipient by injection, or their 
presence be effected by active immunization of the host with 
the same antigens as will be present in a subsequent graft. 
Since our interest in the phenomenon of enhancement has 
prompted the study to be presented, it seems useful first to 
discuss it in some detail. This phenomenon, too, was first 
demonstrated in studies with transplantable tumours. It was 
found that some tumours paradoxically showed enhanced growth 
despite prior immunization of the recipient to that particular 
tumour. This was most frequently observed with tumours which 
were relatively insensitive to the lytic action of antibody 
and complement in vitro; these were mainly sarcomas. Lymphoid 
tumours, on the other hand, were found to be readily destroyed 
by antibody and complement in vitro, and it was very difficult 
to induce enhancement of the growth of these tumours in vivo. 
Studies by Winn (1960) and Moller and Moller (1962) demonstrated 
that the sensitivity to antibody is related to the concentration 
of antigenic sites on the cell surface. This leads to the conclu-
sion that the enhancement phenomenon can be induced more readily 
if the concentration of antigenic sites with which the antibódy 
reacts, is lower. 
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It should be emphasized that the antiserum must contain 
antibodies against all the transplantation antigens present on 
the donor cells and absent from the recipient cells; otherwise 
the antigens not "covered" are able to induce graft rejection. 
It is therefore difficult to induce enhancement when the genetic 
disparity between donor and recipient is great, i.e. when many 
antigenic differences exist. This is probably why it has proved 
so difficult to achieve significant enhancement of grafts of 
normal tissue, particularly skin grafts. 
It has recently been demonstrated that it is possible to 
induce enhancement for skin grafts in mice if a genetic model 
is chosen in which antigenic differences are confined to only 
a few specificities (McKenzie, Jeekel, Koene and Winn 1970). 
This result has raised the question of the concentration and 
distribution of transplantation antigens on the cells in these 
mouse strains. The study to be presented makes an attempt to 
improve our insight into this question on the basis of in vitro 
investigations. 
Studies which Möller (1961) made in vitro with the aid of 
fluorescein-labelled antibodies, disclosed that the antigenic 
determinants to which the antibodies bind themselves, are loca-
lized on the external cell membrane. This antigen-antibody 
reaction as such, however, does not lead to cell destruction. 
This final step requires the presence of complement: a system 
of nine serum factors. Activation of this complement system 
gives rise to a lesion in the cell membrane, as a result of 
which the separation between intracellular and extracellular 
space is disrupted, and the cell destroyed. This lesion was 
visualized electron-microscopically in the splendid study 
published by Borsos, Humphrey and Dourmashkin in 1964. 
The effect of complement is undoubtedly in part dependent 
on the geometric relations between the antigenic determinants 
on the cell membrane. Additional factors of significance are 
the nature of the antibody bound to the antigenic determinant 
as well as the origin of the complement. Effects observed with 
antibodies of the IgM type differ from those seen with anti-
bodies consisting of IgG. There are sound reasons to assume 
that guinea pig complement requires more antigenic sites for 
its effect than rabbit complement. In principle, these differen-
ces afford the possibility of obtaining information on the dis-
tribution of antigenic determinants on the cell membrane by 
studying the reactions in systems with varying concentrations 
of antibodies and complements. Moreover, they make it possible 
to establish whether antigenic determinants of different speci-
ficity can interact with regard to the binding of specific anti-
bodies and the activation of complement. 
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Studies of the abovementioned effects have so far been made 
largely with the aid of the so-called haemolytic system, in 
which the destruction of red cells in response to red-cell anti-
body and complement is investigated. The advantage of this system 
is that it is relatively simple to measure the degree of cell 
destruction by the amount of haemoglobin released. Winn in parti-
cular has made exhaustive studies of this system, and the study 
to be presented is an extension of his work (Winn 1965) to a 
system which is a closer approximation of the transplantation 
reaction. Specifically, the erythrocytes have been replaced by 
nucleated lymphoid cells in our study, and the red-cell anti-
bodies by antibodies specifically directed against transplanta-
tion antigens. It is by no means a matter of course that the 
results of studies of the haemolytic system should apply also 
to cytolysis of nucleated cells. It is possible that these cells 
are capable of dealing with the damage caused by complement by 
means of a restorative mechanism of an obscure nature (Chambers 
and Fell 1931, Mill 1er-Eberhard, Polley and Nelson 1966). It is 
therefore quite possible that the kinetics of the cytolysis of 
nucleated cells differ from those of the red blood cells. 
A full understanding of this question remains an illusion 
for the time being; and this study is merely an attempt to offer 
a model for this type of research, thus making an modest contri-
bution to the knowledge so far gathered. 
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C H A P T E R 2 
TRANSPLANTATION GENETICS OF THE MOUSE 
The mouse constitutes an excellent model for transplantation 
research, because large numbers of high inbred strains are avail­
able with a constantly homozygous genetic pattern. Moreover, the 
transplantation genetics of the mouse have been studied in detail, 
and the various antigens have been clearly defined. The transplan­
tation or histocompatibility antigens are determined by genetic 
factors: the histocompatibility genes. The sites at which these 
genes are localized on the chromosome are known as histocompati­
bility loci or H-loci. 
For a good understanding of the model used in this study, the 
method used to identify the various Η-loci should first be briefly 
discussed. This method is based on the genetic principle of co-iso-
genicity, and was evolved by Snell (1948, 1958). The co-isogenicity 
concept postulates identity between two individuals except for one 
genetic locus. If the locus by which the individuals differ is a 
Η-locus, then grafts exchanged between these two individuals are 
bound to be rejected. Pure co-isogenicity can occur only as a 
result of mutation. By evolving an ingenious breeding system and 
using injections of tumour tissue, Snell developed a method which 
ensures very close approximation to co-isogenicity between two 
inbred mouse strains. 
The principle of this breeding system can be described as 
follows. A start is made with two inbred strains, A and B, which 
are assumed to possess different alleles on the Η-locus tálleles 
A and B. Both strains being homozygous, strain A animals carry 
two alleles A (AA), while strain В animals carry two alleles В 
(BB). A strain A tumour will grow in an A animal and ultimately 
kill it, for there are no significant antigenic differences be­
tween the strain A tumour and the strain A animal. A strain В 
animal, however, will reject this tumour because it possesses 
13 
the allele В and therefore recognizes the tumour, which contains 
the allele A, as foreign. On the basis of injections of tumour 
tissue, therefore, animals which carry a different allele can be 
distinguished. The purpose is to incorporate the chromosomal 
segment which contains the allele B, in animal A while leaving 
the remainder of the strain A genome unchanged. To achieve this, 
A and В are crossed and an F» generation is made (fig. 1). 
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Fig. 1 Production of a congenie resistant line 
(see text). AA and BB refer to the histo­
compatibility alleles of strain A and 
strain B. 
+ = susceptible to strain A tumour 
- ~ resistant 
G » generation 
When strain A tumour tissue is injected into all F„ animals, 
only the BB animals will survive. These survivors are backcrossed 
to the parental strain A, and all subsequent even generations are 
inoculated with the A tumour. As г result of the repeated back-
crosses to the strain A animals, all genetic information of strain 
В is lost and replaced by the strain A genome. Only the histocom­
patibility allele В remains intact because this is the gene for 
which selection takes place. After 12-14 generations the surviving 
animals will be virtually identical to strain A except for the 
histocompatibility gene B. In this generation, two surviving ani­
mals are then crossed, and the co-isogenic strain is obtained. 
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The strains are not purely co-isogenic in the strict sense, 
for in the above described system of breeding, traits which are 
very closely linked to the allele В can be transmitted with it 
to the newly established strain. This is why Snell introduced 
the term congenie, instead of co-isogenic. The newly established 
strains are called congenie resistant strains. The abovementioned 
new strain is designated A.B. A is the symbol of the tumour-
donating strain, and В that of the resistant strain in the ori­
ginal cross'. 
An example of a natural congenie system is the histo-incom-
patibility between males and females of the same inbred strain. 
The Y chromosome contains a weak transplantation antigen. On the 
basis of this single difference, grafts from males to females are 
rejected in some inbred strains. This, however, is only one-way 
histo-incompatibility. Female grafts which lack the Y-linked 
antigen, are not rejected by males of the same inbred strain. 
The development of these congenie resistant strains has made 
it possible to identify the histocompatibility genes and study 
them separately. It was found that the transplantation antigens 
can be divided into two groups. There are strong transplantation 
antigens, which give rise to an intensive transplantation reac­
tion with, for example, rejection of a skin graft within 10-15 
days. The other group comprises the less intensive transplanta­
tion reactions with graft rejection within 15-300 days. 
The genetic information for the strong antigens is localized 
in a single chromosomal region: the histocompatibility-2 locus 
(H-2 locus) on the IXth linkage group. More than 20 alleles of 
this locus are now known, which are designated H-2 , H-2 , etc. 
We know, chiefly from serological studies, that each allele as 
such is complex and determines a varying number of antigenic 
specificities. These are designated H-2.1, H-2.2, etc. Some 40 
specificities are known. Many antigenic specificities are shared 
by several alleles, but some others (private antigens) are pre­
sent on only a single allele. 
Recombination studies have demonstrated that the genetic 
determinants of the antigenic specificities are arranged on the 
chromosome in a particular linear order (Shreff1er 1970). The 
H-2 region proves to consist of 5 subregions which can be sepa­
rated by crossing over. The genetic determinant of one particular 
ψ
 For the sake of convenience it was assumed in the example 
that both the A and the В strain were inbred. However, the 
В strain need not necessarily be an inbred strain. The same 
result can be obtained with a non-inbred strain because se­
lection takes place only for the H-locus. 
15 
antigen is always localized in the same particular subregion. 
The subregions localized at the two ends of the H-2 locus, have 
been most fully studied because due to their relatively large 
distance apart, they are most frequently involved in recombi­
nations. These two subregions are known as D end and К end. The 
antigenic specificities governed by these subregions are known 
as D end antigens and К end antigens, and the antibodies which 
correspond with these antigens are known as anti D end and anti 
К end antibodies. 
Snell and co-workers have made the greatest contribution 
to the analysis of the genetic structure. The data on the anti­
genic constellation are recorded on the H-2 chart, which is up­
dated at regular intervals (Snell, Hoecker, Amos and Stimpfling 
1964, Shreffier and Snell 1969). 
The weak or non H-2 transplantation antigens are localized 
in different linkage groups. In the mouse, 14 non H-2 loci are 
known, which are designated H-1, H-3, H-4 etc. At most of these 
loci, too, a number of allelic forms are present, e.g. H-l , H-l . 
etc. As we mentioned, a weak transplantation antigen is found on 
the Y chromosome. A minor histocompatibility locus is likewise 
found on the X chromosome. Although the non H-2 antigens are weak 
antigens, combinations of various non H-2 antigens can have a 
cumulative effect so that an intensive transplantation reaction 
nevertheless occurs (Graff, Silvers, Billingham, Hildemann and 
Snell 1966). 
In view of the above data it is evident that two groups of 
congenie resistant strains can be produced. When the parental 
strains differ on the H-2 locus, a H-2 congenie strain will be 
bred. In order to obtain a non H-2 congenie strain, the parental 
strains should be of the same H-2 type. 
Immunization of suitable combinations of H-2 congenie 
strains has made it possible to prepare antisera which contain 
antibodies directed against a limited number of antigenic speci­
ficities. With these, a further analysis of the H-2 locus can 
be carried out. Most of these antisera are prepared at the Jack­
son Laboratory, Bar Harbor, Maine. The characteristics are com­
piled by Snell (1968). 
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C H A P T E R 3 
THE ACTION OF COMPLEMENT 
Introduction 
The complement system has been defined by Mayer (1965) as 
"a cytocidal reaction system which is activated by antigen-anti-
"body complexes or aggregated γ-globulin or by certain other 
"materials". 
The system consists of nine serum factors which interact 
in a definite sequence. Mayer's definition is too limited, as 
it has become clear that a number of other reactions are like­
wise mediated by complement, even though not all nine components 
are required for this purpose. In this context we are alluding 
to such phenomena as immunophagocytosis, immune adherence, Chemo­
taxis and anaphylaxis. These phenomena are not within the scope 
of this study and need not be discussed here. For reviews, the 
interested reader may be referred to Mayer (1961), Lachmann 
(1968), Pondman (1969) and Audran (1970). 
Our attention focuses on the mechanism of the cytocidal 
action of complement. As mentioned earlier, the reaction has 
been most fully studied in a system consisting of sheep red 
cells, anti-red cell antibody (which is in fact an anti-Fors-
mann haemolysin) and guinea pig complement. It has been demon­
strated that the principles of complement activation in this 
system also apply to other systems, e.g. bacteriolysis (Muschel 
1965) or immune lysis of nucleated cells (Ross and Lepow 1960). 
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Activation of complement 
The course of complement activation in relation to cyto-
lysis is shown schematically in fig. 2. The antigenic site (S) 
on the erythrocyte is first sensitized with the antibody (A). 
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Fig. 2 Schematic representation of 
the mechanism of complement 
activation. 
S = antigenic site on cell; 
A =• antibody; С,, C, etc. = 
complement components; 
С 1 etc. = activated form; 
At the antigenic site the antibody combines with a specific part 
of the molecule, the so-called Fab fragment. This fragment can 
be separated from the total molecule by treatment with papain. 
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The remainder, the so-called Fc fragment, is responsible with 
an intact molecule for complement activation. For, if Fab frag­
ments without Fc fragment are combined with the antigenic site, 
then complement fixation is greatly reduced. 
The first complement component (CI) is a macromolecule 
which can be artificially split up into three subcomponents: 
Clq, Clr and Cls. The division is achieved by extracting cal­
cium with the aid of chelating agents. Component Clq combines 
with the Fc fragment of the antibody molecule. Once this combi­
nation is achieved, component Cls (a pro-esterase) is trans­
formed into Cl-esterase under the influence of component Clr 
which acts as protease. Calcium ions are required for this reac­
tion. Levy and Lepow (1959) demonstrated that normal serum con­
tains an inhibitor of Cl-esterase. This factor is able to in­
hibit the enzymatic function of Cl-esterase, thus preventing 
spontaneous complement activation. In the vicinity of a cell 
sensitized with antibody, however, the concentration of comple­
ment becomes so high that the inhibitory effect on Cl-esterase 
is overwhelmed. Moreover, the velocity of the inhibitory reac­
tion is lower than that of the CI activation. 
Cl-esterase will bring C4 in an activated state. During 
this activated state, CA is able to combine with receptors on 
the cell membrane or on the antibody. C4 is active only during 
a short time. If it does not combine with a receptor, it is 
transformed into an inactive form (С4і). Most of C4 combines 
with the cell membrane, while only a small amount is adsorbed 
by SAC1. The mechanism underlying this process is obscure. 
The formation of SAC1,4,2 takes place in two consecutive 
stages. In the first stage, C2 is adsorbed onto SAC1,4; this 
reaction occurs only in the presence of magnesium ions. In 
the second stage, the adsorbed £2 is split into two parts by 
Cl-esterase. The active part (C2) combines with SAC1,4 whereas 
the inactive part (C2i) enters the fluid phase, The intermediate 
SAC1,4,2 is not very stable. The component C2 is readily released 
from the complex and.can be found in the fluid phase in an inac-
tive form called C2a . The half-life of SAC1,4,2 is about 10 
hours at 0 C, and about 10 minutes at 37 C. The complex SAC1,4 
which remains after release of C2 can react with a new C2 compo-
nent and once again form a SAC],4,2_complex. 
Ohce this stage is attained, CI is no longer required for 
the reaction. It can be easily eluted from the complex with 
EDTA. The behaviour of the complex SAC4,2 is the same as that 
of SAC1,4,2. This is why the symbol CI is discarded from this 
stage on. 
The C4,2 complex acts as an enzyme which has C3 as its 
natural substrate. It is also known as C3 convertase. It is 
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by the action of this enzyme that C3 is activated. The activated 
C3 can become fixed, or it remains free and decays to an inactive 
form (C3i). One site of C4,2 is able to catalyse the fixation of 
several hundred C3 molecules to receptor sites on the cell mem-
brane, but it seems likely that only C3 molecules bound in close 
proximity to the C4,2 can induce haemolysis. 
The action of C5, C6 and C7 leads to the formation of a 
stable intermediate. There is no decay at 37 C. When the subse-
quent complement components are added after several hours' incu-
bation at this temperature, lysis still occurs. C5, C6 and C7 
act as a functional unit in their reaction with SAC4,2,3, but 
the exact nature of this reaction is not clear. It is uncertain 
whether any part of the C5,C6,C7 complex becomes fixed to the 
cell. Most of it is released in the solution as a complex with 
chemotactic properties. 
C8 reacts with the stable intermediate and is bound on the 
cell membrane. In the next step, C9 reacts with the active site 
of C8. This results in a lesion of the cell membrane (ST). As 
we mentioned, these lesions can be electron-microscopically 
visualized as small "holes" (Borsos et al. 1964). These holes 
are considered to be local changes in the lipid layer of the 
cell membrane. Once ST is formed, the cell lyses spontaneously 
in the absence of any serum factor. The chemical process by 
which the lesion of the cell membrane is brought about, is 
still obscure. 
We have thus described the phenomenon of cytolysis in terms 
of reactive sites. Many such sites are usually present on the 
surface of one cell. Mayer (1965) analysed the kinetics of the 
different steps in complement activation and, on the basis of 
his findings, developed his "single hit theory". This theory 
postulates that the production of only one ST on a cell is suf-
ficient to induce its lysis. The successive hits which may occur 
on one cell do not interact to induce cytolysis, but are inde-
pendent events. Borsos et al. (1964) demonstrated that the num-
ber of damaged sites on the cell as predicted from the single 
hit theory, was remarkably close to the number of holes detected 
by electron microscopy. 
The principle of complement activation is probably the same 
for complements from different sources. However, there are spe-
cies differences which can cause quantitative modification of 
the cytocidal action. These will be discussed in later sections 
of this study. 
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C H A P T E R 4 
SPECIFIC DEFINITION OF THE PURPOSE OF THIS STUDY 
Cytotoxic cell destruction in vitro is a measure of the 
relationship between cell surface antigens, specific antibody, 
and complement. The susceptibility of cells to the destructive 
action of antibody and complement is related to the concentra-
tion of corresponding antigenic sites on the cell surface. 
Studies by Winn (1960, 1962) and Möller et al. (1962) have 
shown that cells susceptible to the lytic action of antibody 
and complement, can absorb much larger amounts of these anti-
bodies than resistant cells. 
The source of complement also plays an important role, for 
it has been established that mouse cells sensitized with allo-
antibody are more efficiently destroyed by rabbit complement 
than by guinea pig complement (Boyse, Old and Thomas 1962, Winn 
1965, Haughton and McGehee 1969). The lastmentioned authors sug-
gested that this difference in effect between the two types of 
complement are caused by the fact that guinea pig complement 
requires two sites sensitized with antibody to be activated, 
whereas rabbit complement needs only one. 
If the hypothesis advanced by Haughton et al. is correct, 
then guinea pig complement should become more efficient as the 
number of reactive sites per unit of cell surface is increased 
(always assuming that the antigens are evenly distributed on 
the cell surface). This situation might be achieved by sensi-
tizing the cells with combinations of antisera which contain 
different specificities, i.e. which are directed against more 
than one antigenic determinant. Two additional requirements must 
be met as well, namely: 
1) the complement should not discriminate between antibodies of 
different specificity; 
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2) the reactive sites of different specificities should be 
localized sufficiently close together to permit the com-
plement activation. 
The first of these two requirements can be assumed to be 
fulfilled. We may regard complement activation as a sort of 
"final common pathway" to effect lysis of the cell, and as 
independent of the antigen-antibody reaction involved. In fact, 
the antigenic determinant against which the antigen is directed 
needs not even to constitute an integral part of the cell mem-
brane. Middlebrook demonstrated in 1950 that erythrocytes coated 
with soluble antigen from, for instance, tubercle bacilli, can 
be haemolysed by addition of complement and antibody specifi-
cally directed against the bacilli. 
The situation is much more complicated with regard to the 
second requirement. For the literature comprises reports on 
synergistic as well as on antagonistic or blocking effects of 
polyspecific sera. Möller et al. (1962) prepared antisera against 
a single type of tumour cells in three different mouse strains. 
The cells were not lysed by anyone of the antisera used alone, 
but were by a combination of the three antisera. A few years 
later, Moller and Eklund (1965) also demonstrated a synergysm 
of anti-ABO and anti-rhesus antibody in the lysis of human lymph-
node cells. Rosse and Parker (1968) demonstrated that human ery-
throcytes sensitized with three anti-rhesus sera containing dif-
ferent specificities, were able to bind complement factor С la, 
which was not bound when antiserum against one specificity was 
used. The source of complement used in all the abovementioned 
studies was fresh guinea pig serum. Ivaskovâ, Vybíralová, Raue, 
Démant and Ivänyi (1969) demonstrated a similar synergism of HLA 
antibodies. Although they do not specifically state this in their 
publication, it seems likely that they used rabbit complement in 
their study. However, they rightly pointed out that their experi-
ments disregarded possible anticomplementary effects as well as 
differences in molecular classes of antibody between the sera 
used. On the other hand Boyse, Old and Stockert (1968) and Kristo-
fovâ, Lengerovâ and Rejzokovâ (1970) demonstrated with mouse cells 
that a single antibody specificity can counteract the absorption 
of another antibody, probably by a blocking effect. Both groups 
of investigators made use of rabbit complement. In 1968, Cress-
well and Sanderson described a blocking effect of H-2 antibodies 
in a cytotoxic test in which they used guinea pig complement. 
These differences must be assumed to depend on the geometric 
localization of the antigenic sites: if these are very close to-
gether on the cell surface, then we may assume that an antigen-
antibody complex constitutes a steric obstacle against the bind-
ing of antibody to a nearby antigenic determinant. If the anti-
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genie sites are so distributed as to give no access to comple­
ment individually, but only collectively, then synergism may be 
expected. Finally, the sites may be spaced so far apart that 
there can be neither a reciprocal unfavourable influence nor 
an improved access to complement upon collective activation. 
The study by Boyse et al. (1968) demonstrated that blocking 
occurred only if combinations of anti D end antibodies were used. 
No blocking effect was demonstrable, however, with mixtures of 
anti D and anti К specificities. These results suggest that, on 
the cell surface, the distance between D end antigenic determi­
nants of different specificity is smaller than the distance be­
tween D end and К end antigens. 
In order to study these blocking and synergistic effects 
in the system we used, we first carried out titrations, at an 
excess of two types of complement (rabbit and guinea pig comple­
ment), with optimally monospecific antisera; next we combined 
these antisera to polyspecific antisera of known composition. 
The sera were so chosen as to ensure that sera with only anti D 
end antibodies as well as sera with only anti К end antibodies 
were represented in the material. The results of this investi­
gation are presented in chapter 6 under the heading "antiserum 
titrations". In addition, we carried out titrations with the two 
types of complement at constant antibody concentrations. The data 
thus obtained are presented in chapter 7 under the heading "com­
plement titrations". 
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C H A P T E R 
THE TEST SYSTEM USED IN THIS STUDY 
The test system used in this study can be described on the 
basis of the schema: , 
., , complement , . , Antigen-bearing target cell + antibody * -—-• lysis of 
target cell. 
Tumour cells of the lymphoid leukaemia type (L1210 cells) 
were used as antigen-bearing target cells. The tumour in ques­
tion was originally induced in the DBA/2 mouse strain by skin 
paintings with 0.2% methylcholanthrene in ethyl ether (Law, Dunn, 
Boyle and Miller 1949). The tumour can be easily passaged in 
DBA/2J mice and in (C57B1/6J χ DBA/2J)F] hybrids. We usually 
employed the latter strain. 
Ascites develops within a few days of intraperitoneal injec­
tion of 10° tumour cells. The ascites fluid is rich in tumour 
cells and can be simply used for preparation of a cell suspen­
sion. These cells are quite suitable for use in a cytotoxic test 
and prove to be much less vulnerable to non-specific trauma than 
normal mouse lymphoid cells. 
The transformation of normal tissue into tumour tissue is 
associated with acquisition of new antigenic determinants, in­
cluding tumour specific transplantation antigens (TSTA). Foley 
was the first to demonstrate the immunological function of TSTA 
in 1953. When he inoculated a mouse with tumour tissue and re­
moved the inoculate before the animal succumbed to progressive 
tumour growth, a second inoculate proved not to grow: the mouse 
had become immune to the tumour, and this immunity proved to be 
specific because other methylcholanthrene-induced tumours were 
not rejected. 
The TSTA formed in chemically induced tumours prove to have 
a different antigenic specificity in virtually all cases. This 
also applies to tumours induced by means of the same carcinogen 
in different animals of the same inbred strain (Klein and Klein 
1962, Holmes, Morton, Schidlovsky and Trahan 1971). 
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Since the DBA/2 mouse carries the H-2 allele, L1210 tumour 
cells can be expected to possess the H-2 antigens. To eliminate 
the possibility of the cell losing one or several H-2 antigens 
in its transformation to tumour cell, an earlier study had focused 
on the question whether H-2" antigens could be demonstrated on the 
L1210 cell (Koene, McKenzie, Painter, Sachs, Winn and Russell 1970). 
The H-2 specificities 3, 4, 8, 13, 28 and 31 were demonstrated. All 
antigenic specificities which we wish to examine in this study,were 
present. 
The ascites fluid formed following intraperitoneal injection 
of tumour cells, is usually highly haemorrhagic. The erythrocytes 
must be removed before use. For this purpose the peritoneal cavity 
of the ascites-bearing mouse is washed out with a Тгіз-ШдСІ solu­
tion, and the cell suspension thus obtained is then incubated at 
370C for 10 minutes. This method, which is virtually the same as 
that described by Boyle (1968), is used to lyse the red cells. The 
cells are then centrifuged in a refrigerated centrifuge (40C) at 
200 j> for 5 minutes, and suspended in Hank's balanced salt solu­
tion (BSS) (Hank and Wallace 1949), without sodium bicarbonate, to 
which foetal calf serum has been added in advance to a concentra­
tion of 5%. The pH of this medium is 6.8. The final concentration 
of cells is adjusted to 2 χ 10? cells per ml. 
A number of allo-antisera were used as antibody in this study. 
All were specifically directed against one or two H-2^ antigenic 
determinants. A survey of the sera used is presented in Table I. 
TABLE I: SPECIFICITIES OF ALLO-AHTISERA TESTED 
Antiseruin H-2 specificities H-2 specificities directed 
present against H-2 antigens 
(ΒΙΟ X A) anti B10.D2X 31 31 
(AKR.M κ C3H.SW) anti BIO.A 4 4 
(ΒΙΟ χ A.SW) anti ΒΙΟ.M 8,9 8 
(BIO.Br χ 129) anti BIO.AKM 13,30 13 
(Α.CA χ BIO.Br) anti A.SW 3,19,28 3,28 
ascites fluid (see text) 
With one exception, the allo-antisera were obtained from the Trans­
plantation and Immunology Branch of the National Institute for 
Allergic and Infectious Diseases (Bethesda, Maryland), which is 
provided with tested sera by Dr G.D, Snell (Jackson Laboratory, 
Bar Harbor, Maine). Their characteristics are compiled in the 
"Catalog of mouse allo-antisera 1968". 
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The hetero-antiserum we used, was kindly supplied by Dr 
D.H. Sachs (Department of Surgery, Massachusetts General Hospi­
tal, Boston). 
The preparation of antisera is best discussed with reference 
to the anti H-2.31 allo-antiserum which we ourselves prepared in 
the laboratory. 
The principle of preparation is based on immunization of the 
recipient with donor cells possessing only a few antigenic deter­
minants not present on the recipient's tissues, This ensures the 
formation, in the recipient, of antibodies directed only against 
one or a few known specificities of the donor. 
Anti H-2.31 antiserum was induced in female (C57B1 /lOScSn 
χ A/Jax)F] = (ΒΙΟ χ A)?] hybrids by multiple intraperitoneal 
injections of B10.D2 lymphoid cells. The cells were obtained 
from lymphnodes, spleen and thymus, and made into a cell sus­
pension by pressing the tissue through a 60-gauge stainless 
steel mesh into Hank's BSS. 
The antigenic determinants of the mouse strains used are 
presented in table II, which shows that the only antigenic deter­
minant present in the B10.D2 strain and absent from the A/Jax 
strain, is specificity H-2.31. 
TABLE II: H-2 ANTIGENIC SPECIFICITIES OF THE THREE MOUSE STRAINS USED 
FOR RAISING ΑΝΤΙ H-2.31 SERUM 
Strain H-2 Allele Antigenic specificities 
A/Jax a ι 3 4 5 6 8 10 11 13 23 25 27 28 29 
C57B1/10 b 2 5 6 22 27 28 29 33 
B10.D2 d 3 4 6 8 10 13 27 28 29 © 
But in addition to H-2 differences there could also be non H-2 
differences between these two strains. Our effort to eliminate 
these makes use of the fact that the B10.D2 strain is congenie 
with the C57B1/10 strain, that is to say: these two strains 
differ only at the H-2 locus. The hybrid (ΒΙΟ χ A)F| should 
therefore carry all non H-2 antigenic determinants of the B10.D2 
strain, so that immunization of the (ΒΙΟ χ A)Fi strain with 
B10.D2 cells should lead to formation of antibodies specifi­
cally directed against specificity H-2.31. 
The majority of investigators obtain the antiserum by 
bloodletting from the tail vein or from the retro-orbital venous 
plexus. Only minute amounts of antiserum can thus be collected 
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per mouse. The technique we use, which was first described by 
Munoz in 1957, enables us to produce larger amounts of antibody 
in a simple way. 
We injected lymphoid cells intraperitoneally in complete 
Freund's adjuvant (CFA). It is possible that a more intensive 
humoral response occurs as a result of its addition (Freund 
1951). The injections were given weekly. Marked ascites was 
found to form in the test animals after a few weeks. In the 
ascites fluid, antibody was demonstrable at a titre which 
equalled that of the serum. The procedure can be described 
in detail as follows. 
1. Recipient (ΒΙΟ χ A)Fi is injected every 1-2 weeks with 
1-2 χ 107 lymphoid cells of B10.D2. 
2. Intraperitoneal injections of 0.25 ml in CFA are given 
(equal volumes of cells and adjuvant). 
3. Ascites forms after 4-5 injections and is tapped every 
1-2 weeks. 
4. Further immunization with cells without adjuvant. 
It should be pointed out that Davies (1969) demonstrated 
a weak reaction of H-2.31 serum with F/St (H-2n) mouse cells 
as well as with DBA/1(Н-2Я) cells. This might imply that this 
serum contains yet another specificity, the corresponding anti­
gen of which should be present in R-Zd, H-2 n and Н-2Я. Davies 
designated this specificity H-2.34. In the antiserum we pre­
pared, too, a weak reaction with DBA/1 cells was demonstrable. 
Absorption of the serum with 1θ8 DBA/1 cells, however, proved 
incapable of abolishing the anti-31 activity. The titre with 
B10.D2 cells remained virtually unchanged after absorption. This 
means that DBA/1 possesses no antigen 31 and that the reaction 
with the serum should therefore be based on another specificity. 
Actually, therefore, the antiserum contains more than one speci­
ficity, and should be designated H-2.31,34. The reaction against 
H-2.34, however, is weak. With all subsequent references to anti 
H-2.31, it should be borne in mind that this serum contains at 
least one more specificity. Other unknown specificities may be 
present, but the likelihood of finding these is decreased by 
using F] hybrids as recipients in the immunization procedure. 
Because these animals are heterozygous, more antigens will be 
represented and hence the probability of finding antigenic dif­
ferences between donor and recipient should be less than in 
cases where homozygous recipients are used. 
As we mentioned, the hetero-antiserum used was supplied by 
Sachs. In a splendid study (Sachs et al. 1971), he demonstrated 
that hetero-antisera can recognize not only "species-specific" 
antigens but can also detect H-2 allo-antigens. Sachs prepared 
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a rat anti B10.D2 lymphocyte serum by intraperitoneal injection 
of B10.D2 lymphocytes into Lewis rats, followed by weekly booster 
injections of these cells. The serum sample used in this study 
had been obtained 8 weeks after the first injection. Before use, 
it had been heat-inactivated at 560C for 45 minutes. This abolishes 
complement activity by inactivating the heat-unstable components 
CI and C2 (Rabat and Mayer 1961). This serum showed an equal acti­
vity against B10.D2(H-2d) and B10.Br(H-2k) lymphocytes. The cyto­
toxic activity against В10.Br cells was abolished by prior absorp­
tion with 6 χ ΙΟ** BIO.Br cells per ml serum. After this absorption, 
however, cytotoxic activity against B10.D2 cells persisted; further 
absorption with BIO.Br cells likewise failed to abolish this acti­
vity. It was concluded that the serum contained antibodies detec­
ting H-2° allo-antigens and mouse "species-specific" antigens, and 
that consequently H-2 specificities can be detected across a spe­
cies barrier. After absorption with (ΒΙΟ χ A)Fi lymphoid cells it 
was shown that this serum was monospecific, containing antibodies 
reactive only with H-2.31 (Sachs et al. 1970). Both the non-ab­
sorbed and the absorbed serum were used in our study. 
The molecular class of the antibodies used can be of great 
importance in complement activation. Winn (1965) demonstrated 
that guinea pig complement can be activated more readily by IgM 
than by IgG antibodies. This fact is probably related to a dif­
ference in complement fixation by the two classes of antibody. 
Borsos and Rapp (1965) suggested that a single molecule of IgM 
suffices to activate guinea pig complement, whereas two adjacent 
molecules of IgG are required to obtain this effect. It is to be 
expected that the cell must be sensitized with many IgG molecules 
before a situation arises in which two molecules are in juxtapo­
sition. It was found that at least 100 IgG molecules are required 
to fix guinea pig complement, for which purpose only a single IgM 
molecule sufficed (Humphrey and Dourmashkin 1965). All these stu­
dies were carried out with the aid of rabbit antibody, guinea pig 
complement and sheep red cells. A study by Andersson, Wigzell and 
Klein (1967), however, showed that the same applies to mouse allo-
antibody, guinea pig complement and nucleated cells. Although 
these authors all seem to agree that IgM is more efficient with 
guinea pig complement, much remains to be clarified. It was shown 
in a recent report by Frank and Gaither (1970a, 1970b) that IgM 
is not always more active in the haemolytic system. This is the 
case only if excess antibody is used and if the reaction is car­
ried out at 370C. In a limited antibody system at 370C, IgG be­
came more efficient at certain antiserum dilutions. They also 
demonstrated that, at A0C, the efficiency of IgM fell to very 
low levels, whereas IgG activity remained relatively unchanged. 
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It therefore seems important to establish the class of antibody 
present in the antiserum before drawing conclusions on activity, 
especially when comparing reactions with complement from different 
sources, 
In the present study, the molecular class of the antibodies 
used was established with the aid of 2-mercapto-ethanol. Treat-
ment of antisera with this substance can be presumed to destroy 
IgM activity (Uhr and Finkelstein 1963). Sera were incubated in 
a final concentration of 0.1 M 2-mercapto-ethanol for 30 minutes 
at 370C. After treatment the sera were dialysed against phosphate 
buffered saline to remove excess 2-mercapto-ethanol, The cyto-
toxic activities of the sera did not change after this treatment. 
In view of this finding it is likely that all antisera contained 
mainly IgG antibodies. 
The complement used in this study came from two sources: 
guinea pig and rabbit. As we pointed out, there are substantial 
differences in activity between complements from certain species. 
Boyse et al. (1962) demonstrated that mouse lymphoid cells sensi-
tized with allo-antibody were much more effectively lysed by 
rabbit complement than by guinea pig complement. Later studies 
by Winn (1965) and by Haughton et al. (1969) confirmed these 
findings. The lastmentioned authors explained the difference 
in efficiency between the two types of complement by suggesting 
that guinea pig complement probably requires two antigen-anti-
body complexes to become activated, whereas a single complex 
is sufficient for rabbit complement. These problems will be 
further discussed in subsequent chapters. 
Fresh lyophilized guinea pig serum was obtained from Difco 
Laboratories, Detroit, Michigan. Several lyophilized samples were 
reconstituted to the original volume with distilled water, pooled 
and stored at -70oC in one ml aliquots, 
Fresh frozen serum from New Zealand rabbits was used as a 
source of rabbit complement. Rabbit serum often contains a natural 
circulating antibody against mouse cells, which makes it toxic in 
the test. It was therefore frequently necessary to test sera from 
10-20 rabbits before a non-toxic serum was obtained. Some investi-
gators have tried to remove the circulating antibody by absorption 
with mouse lymphoid cells at 0oC. In our experience, however, the 
absorption also resulted in greatly reduced complement activity 
which made the serum unsuitable for titrations. This is why in 
this study we only used non-absorbed sera which were found non-
toxic to mouse lymphoid cells. 
Lysis of target cells can be measured by a number of methods. 
The oldest and most commonly used technique is the trypan blue dye 
exclusion method, first described by Pappenheimer (1917) and later 
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modified by Gorer et al. (1956). This method makes use of the fact 
that dead cells take up trypan blue whereas live cells do not. By 
counting the percentage of stained cells under a microscope, a 
measure of the number of cells actually killed in a cell suspen­
sion can be obtained. The disadvantages of this method are its 
inaccuracies introduced by subjective errors, and the need to 
read results within a few hours because, otherwise, the number 
of dead cells in the controls increases markedly. 
For this study we made use of the ^^Cr release assay, described 
by Goodman in 1961. He introduced a technique which employed radio­
isotopes as indicator system. The cells to be studied are labelled 
with -''Cr, which is intracellularly bound. When the cell lyses, the 
isotope is released and, after centrifugation, the amount of radio­
activity released can be measured in the supernatant of the cell 
suspension. With the use of this method, results are reproducible 
(Sanderson 1964), and the counting need not be done immediately so 
that several tests can be run simultaneously. Wigzell (1965) demon­
strated that the test is as sensitive as the trypan blue method, 
while its reproducibility is evidently better. Like Goodman (1961), 
he found that some 75% of the isotope is released upon the death of 
the cell. The remaining 25% is firmly bound to larger cellular com­
ponents which precipitate together with the intact cells during 
centrifugation. Sanderson (1964), who studied the kinetics of the 
assay in detail, likewise found that 100% cytolysis with the trypan 
blue method corresponded to 70-80% isotope release. 
In different experiments, we used one of two methods for the 
cytotoxic test: the one stage test and the two stage test. The two 
methods differ only in that in the one stage test the cytotoxic 
reaction occurs in the antiserum milieu, whereas in the two stage 
test the antiserum, after incubation with the target cells, is 
replaced by another medium. This is done in order to eliminate 
the anticomplementary activity of mouse serum. In detail, the 
procedures were as follows. 
Labelling of cells. One ml of the cell suspension was incubated 
at 370C during 45 minutes with 0.1 ml Ка^СгОд in saline. The 
isotope was obtained from Nuclear Chicago, cat.no.CJS-1P; 0.1 ml 
sodium Chromate represented 0.1 mC radioactivity. During incuba­
tion, the sample was kept in continuous movement to prevent pre­
cipitation of cells. After incubation, the cells were washed three 
times in Hank's BSS in order to remove the free ^'Cr, The final 
volume was adjusted to a concentration of 10" cells per ml. 
In preliminary studies we used medium 199 as incubation medium 
(Morgan, Morter and Parker 1950). We found, however, that the cells 
incorporated twice as much Cr when incubated with Hank's BSS to 
which no НаНСОз had been added. This affords an obvious advantage: 
when the 51cr label is higher, smaller amounts of cells can be used 
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in the test, thus enhancing its sensitivity. We have not analysed 
the cause of the higher uptake in Hank's BSS. Since we did not add 
ЫаНСОз, it seems probable that it is related to the pH of the solu­
tion. 
One stage test. We used the method described by Sanderson (1964) 
with minor modifications: 50 \il antiserum and 50 yl cell suspension 
(5 χ lO^cells) were incubated with 50 yl complement in a water bath 
at 370C during 30 minutes. After 15 minutes' incubation the cells 
were shaken. After incubation the samples were centrifuged in a re­
frigerated centrifuge (40C) at 200 £ for 5 minutes. Next, 50 pi of 
the supernatant was removed and used for measurement of radioactivi­
ty in a well-type scintillation counter (Packard Auto-Gamma Spectro­
meter) . 
Two stage test. 5 χ 10 cells (50 μΐ) were sensitized with 50 μΐ 
antiserum by incubation at 40C during 30 minutes. The suspension 
was then centrifuged and the supernatants were removed simply by 
shaking out the tubes. No cells were lost in this procedure, as 
we have demonstrated by control counts of the available radioacti­
vity before and after removal of the supernatants. Next, 50 yl 
complement and 100 yl of Hank's BSS were added. The subsequent 
steps were the same as in the one stage test, 
Controls. In all tests, the following controls were used. 
1. Cell control: 50 yl cells + 100 yl Hank's BSS. 
2. Antibody control: 50 yl cells + 50 yl undiluted antiserum + 
50 yl Hank's BSS. 
3. Complement control: 50 yl cells + 50 yl complement (RC or GPC) 
+ 50 yl Hank's BSS. 
The maximum lysis in the control tubes was 15%, but in most 
cases it was less than 10%. 
Calculation of lysis percentage. When repeatedly frozen and thawed, 
L1210 cells release 80% of the total label incorporated. As we men­
tioned, this value was found also by Sanderson, who used normal 
lymphoid cells. We have therefore taken this 80% release as equi­
valent to 100% lysis. The 80% value may not represent exactly 100% 
lysis in all serological systems, but in these experiments it has 
proved to be a convenient (if arbitrary) reference point. The 
exact manner of calculation is given below. 
Total cell label (5 χ loVells): A counts per minute (cpm). 
Release at 100% lysis (calculated): 80 . 
ш
 x A c p m
· 
Counts in 50 yl supernatant: В cpm. 
Total volume being 150 yl, amount of ^Icr released: 3 χ В cpm. 
_ τ . . amount of 5'Cr released .
nn
 3 χ В ,_,_. _ % lysis: — ζ : χ 100 = —ST;— χ 100 = ... %. 
release at 100% lysis 80 . 
ioox A 
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Reverting to the schema given in the opening sentence of 
this chapter, the test system used can be summarized as: 
Í L1210 „ ' allele H-2<> tumour cells ι 
ι I 
' , I allo-antieera (table I) 
| ant . serum
 h e t e r o . a n t 1 S e r u m 
rabbit complement 
complement
 g u i n e a p l g complement 
lysis Cr r e l e a s e a s s a y 
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C H A P T E R 6 
ANTISERUM TITRATIONS 
All antisera were tested in serial dilutions (1.5 fold or 
2 fold steps) with excess rabbit or guinea pig complement, ob­
tained by adding complement in a dilution of 1/8. Mixtures of 
allo-antisera were prepared by combining equal volumes of sepa­
rate antisera. The results of each test were plotted on log pro-
bit paper. To obtain 50% lysis, a line of best fit was drawn. 
The antibody titre was expressed in cytotoxic units (CTU) per 
μΐ. One CTU is defined as the amount of antibody which gives 
50% lysis. An example of the actual calculation is given below. 
An antiserum gives 50% lysis in a dilution of, say, 1/100. 
This means that a dilution of 1/100 contains 1 CTU. The undiluted 
sample therefore contains 100 CTU. Since 50 yl serum is used in 
the test, the cytotoxic activity must be 100 _ „„„ 
' -Γ7Γ = 2 CTU per pi. 
TABLE III: EFFECTS OF TWO COMPLEMENT PREPARATIONS ON THE CYTOLYSIS 
OF L1210 CELLS; CYTOTOXIC ACTIVITIES OF ALLO-ANTISERA 
TESTED SEPARATELY 
Specificities 
31 
4 
3,28 
Cytotoxic activity 
Rabbit C x 
(CTU/wl) 
12.86 
8.30 
28.18 
Guinea Pig C x x 
(CTU/μΙ) 
1.16 
0.36 
1.46 
Duplicate titrations. Relative S.E.M. 5.8% 
x x
 Triplicate titrations. Relative S.E.M. 7.4% 
Abbreviations in this and following tables: 
С = complement; CTU = cytotoxic units; 
S.E.M. = standard error of the mean. 
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Allo-antíbody 
The results of the titrations of the separate antisera are 
presented in table III and fig. 3. It is evident that the cyto-
toxic activity of all sera is significantly lower with guinea 
pig complement than with rabbit complement, 
14 116 164 1256 11024 
antiserum dilution 
Figure 3: Effects of two complement preparations on the 
cytolysis of L1210 cells. Antiserum titrations 
with allo-antisera used separately. 
Abbreviations in this and following figures: 
RC = rabbit complement; GPC 
plement. 
guinea pig com-
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The two antisera H-2.8 and H-2.13 showed no activity with 
guinea pig complement, whereas there was definite cytolysis in 
the presence of rabbit complement. The results of these titra­
tions are shown in table IV. 
TABLE IV: EFFECTS OF TWO COMPLEMENT PREPABATIONS ON THE CYTOLYSIS 
OF L1210 CELLS. CYTOTOXIC ACTIVITIES OF ALLO-ANTISERA 
Η-2.β AND H-2.13 
Specificity Cytotoxic activity 
Rabbit С Guinea Pig С 
one stage test two stage test 
(CTU/μΙ) (CTU/yl) (CTU/wl) 
β 
13 
2.17 
1.14 
no activity 
no activity 
0.15 
0.11 
However, when the same titrations were carried out in a two stage 
test in which anticomplementary effects were almost completely 
excluded, these two particular sera showed activity also with 
guinea pig complement, demonstrating that in these cases anti­
complementary factors played a decisive role. Nevertheless, the 
cytotoxic activity with guinea pig complement remained defini­
tely lower than that with rabbit complement. The titration curves 
for both sera are presented in fig. A. 
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14 116 164 1256 11024 
antiserum dilution 
Figure 4: Effects of two complement preparations on the 
cytolysis of L1210 cells. Antiserum titrations 
with allo-antisera H-2.8 and H-2.13 ( one 
stage test, two stage test). 
Mixtures of allo-antibody 
The cytotoxic activity of the antiserum mixtures tested, 
is shown in table V. The actual titrations are given in fig. 5. 
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TABLE V: EFFECTS OF TWO COMPLEMENT PREPAHATIONS ON THE CYTOLYSIS OF L1210 CELLS. 
CYTOTOXIC ACTIVITIES OF MIXTURES OF ALLO-ANTISERA 
S p e c l f i c i t i e a 
31 + 4 
31 + 3,28 
4 + 3,28 
3 1 + 4 + 3 ,28 
measured 
(CTU/μΙ) 
8 .04 
16 .72 
14.38 
1 6 . 2 3 
Rabbit С 
expected 3 1 3 " 1 
(CTU/μΙ) 
10.58 
2 0 . 5 2 
18.24 
16.44 
Cytotoxi i 
pt 
< 0 . 0 1 
< 0 . 0 2 
< 0 . 0 2 
>0.75 
з a c t i v i t y 
Guinea Pig С 
measured3"1 
(CTO/pi) 
0 .52 
1.36 
1.12 
0 .88 
expected 3 1 3 1 " 
(CTU/μΙ) 
0.76 
1.31 
0.91 
0.99 
pt 
< 0 . 0 1 
>0.75 
< 0 . 0 7 
>0.25 
x
 Duplicate titrations: relative S.E.M. 5.8% 
** Triplicate titrations: relative S.E.M. 7.4% 
XXK
 Maximal expected value calculated from cytotoxic units of separate 
f 
allo-antisera (see text) 
P-value of Student's t test for the differences between measured and 
expected values. 
The maximal expected cytotoxic activity was calculated from 
the cytotoxic units of the separate sera by taking the sum of 
these units and dividing this figure by the amounts of sera used 
in the mixture. For example, the maximal expected value for the 
mixture of antiserum H-2,31 and antiserum H-2.4 was 
—'• τ '•— « 10.58 CTU per yl in the presence of rabbit com­
plement. 
The results presented in table V show that the activities 
measured for both types of complement were in most instances 
equal or below the maximal expected values, demonstrating the 
absence of synergistic effects. In only a single instance was 
the activity measured significantly higher than that calculated. 
This was the case with combination 4 + 3,28 with guinea pig com­
plement. The activity measured was 1,12 CTU/yl, while that cal­
culated was 0.91; the difference was weakly significant (P<0.07). 
In the combination 31 + 3,28 with guinea pig complement the value 
measured (1.36) was likewise higher than that calculated (1.31), 
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anl¡H-2.m>4) 
1 64 1 256 11024 
cinti Н-2(ЗЬЗ, 28) 
[ant]H-2.(31*4»3,28)j 
1-4 116 1-64 1256 1:1024 
antiserum dilution 
Figure 5: Effects of two complement p r e p a r a t i o n s on the 
c y t o l y s i s of LI210 c e l l s . Antiserum t i t r a t i o n s 
with a l lo-ant i serum-tnixtures . 
but this difference was not significant (P> 0,75). In the combi­
nation 4 + 3,28 with guinea pig complement, therefore, a syner­
gistic effect can be suspected. However, another titration with 
guinea pig complement (31 +4) disclosed a blocking effect: the 
activity measured was significantly lower than that calculated 
(P< 0.01). In the combination of three sera (31 + 4 + 3,28), 
these two effects would seem more or less to cancel each other 
out: there was no significant difference between the values 
measured and those calculated. 
In all titrations with rabbit complement but one (31 + 4 + 
3,28), a significantly lower cytotoxic activity was measured 
than could be expected on the basis of the results of titrations 
with the separate sera. This indicates that the sera used in the 
antiserum mixtures show reciprocal blocking effects when rabbit 
complement is used. 
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Hetero-antibody 
The results of titrations of hetero-antiserum (fig. 6) again 
demonstrate that guinea pig complement is less efficient than rab­
bit complement. This applies to the non-absorbed serum, but also 
to the serum absorbed with (ΒΙΟ χ A)F] cells in advance, 
unabsorbed I 
o RC 
•GPC 
1-64 1256 11024 
antiserum dilution 
Figure 6: Effects of two complement preparations on the 
c y t o l y s i s of LI2I0 c e l l s . Antiserum t i t r a t i o n s 
with a hetero-antiserum (rat-anti B10.D2 serum) 
(two stage t e s t ) . 
After absorption, all sera were noticed to show an increase in 
anticomplementary activity; this made it necessary to carry out 
the titrations in a two stage test. 
In order to express the relative efficiency of the two com­
plements, we calculated a ratio by dividing the number of cyto­
toxic units obtained with rabbit complement, by that obtained 
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with guinea pig complement. Table IV shows that this ratio was 
4.94 + 0.50 for the unabsorbed anti-lymphocyte serum. As we dis­
cussed before, mouse species specificities can be removed from 
the serum by absorption with appropriate mouse lymphoid cells, 
leaving only strain specific antibodies in the serum. 
TABLE VI: EFFECTS OF TWO COMPLEMENT PREPARATIONS ON THE CYTOLYSIS OF L1210 
CELLS. CYTOTOXIC ACTIVITY OF A HETERO-ANTISERUM (RAT ANTI B10.D2 
SERUM)X 
Rat anti B10.D2 serum Cytotoxi 
Rabbit С 
(CTlVyl + S.E.M.) 
unabsorbed 6.95 + 0.34 
absorbed 0.92 + 0.18 
с activity 
Guinea Pig С 
(CTU/yl + S.E.M.) 
1.42 + 0.04 
0.18 + 0.02 
Ratio 
RC/GPC + S.E.M. 
4.94 + 0.50 
5.01 + 0.39 
"Duplicate titrations in two stage test 
When this was carried out with (ΒΙΟ χ A)F] lymphoid cells, the 
cytotoxicity with both complements decreased. The ratio, how­
ever, remained virtually unchanged: 5.01 +0,39 (P> 0.75). The 
relative efficiency of guinea pig complement did therefore not 
decrease after removal of many specificities by absorption. No 
distinct synergistic effect between mouse species and H-2 speci­
ficities was observed. 
Maximal release of 5'Cr with rabbit complement and with guinea 
pig complement 
Not only was the cytotoxic activity of the antisera much 
lower in the presence of guinea pig complement, but the maximal 
release of ->lcr obtained in the presence of excess antibody was 
likewise less. It was found that, in all allo-antiserum titra­
tions (fig. 3; fig. 5), the maximal release with guinea pig com­
plement was 10-20% lower than that with rabbit complement. The 
titrations with anti H-2.8 and anti H-2.13 would seem to be an 
exception. In dilution 1:4, the maximal release for guinea pig 
complement equals that for rabbit complement (fig. 4). In these 
tests, however, only a one stage procedure was used for rabbit 
complement, whereas guinea pig complement was tested by a two 
stage procedure. Since both sera show marked anticomplementary 
40 
activity, the maximal release with rabbit complement can be ex­
pected to increase if the titration with rabbit complement were 
carried out in a two stage test, and should attain a value 
exceeding that for guinea pig complement, 
Winn (1962) observed the same phenomenon of submaximal 
release when testing an allo-antiserum in the haemolytic tech­
nique against strain A red blood cells. In most instances he 
found no maximal haemolysis even when large amounts of guinea 
pig complement were used. It might be argued that this finding 
must be related to an amount of antibody insufficient to sensi­
tize the cells, so that maximal lysis could not occur. But Winn 
clearly demonstrated that a large excess of antibody was present 
in his experiments. 
The phenomenon of submaximal release with guinea pig com­
plement might be due to anticomplementary factors, for these 
factors are known to affect guinea pig complement much more 
than rabbit complement (Winn 1965). However, in a two stage 
test in which the supernatant mouse sera were removed after in­
cubation, thus eliminating anticomplementary factors, there still 
remained an unequivocal difference in maximal lysis between rab­
bit complement and guinea pig complement, the latter giving lower 
figures than the former (fig. 7). To exclude the possibility that 
this finding was related to the particular kind of assay used, 
the viability of sensitized cells after incubation with guinea 
pig complement was tested with the trypan blue dye exclusion method. 
We did not analyse this problem systematically, but in the few ex­
periments performed the percentages of dead cells counted were the 
same as the percentages calculated from the ^ ІСг release. This 
suggests that the finding of submaximal release is not confined 
to the 5'Cr assay. 
% lysis 
100 
Θ0 
60 
40 
20 
14 116 1 64 1256 1 1024 
antiserum dilution 
Figure 7: Effects of two complement p r e p a r a t i o n s on the 
c y t o l y s i s of L1210 c e l l s . Antiserum t i t r a t i o n s 
with a l lo-ant i se rum H-2.31 (two stage t e s t ) . 
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Unlike that obtained with allo-antisera, the maximal release 
obtained with the hetero-antiserum was the same with rabbit as 
with guinea pig complement. This is clearly demonstrated in fig. 
6, which shows that in the titrations of the unabsorbed hetero-
antiserum, only minor differences existed between the maximal 
lysis values for the two complements, 
Discussion 
The results of titrations with allo-antisera warrant the 
conclusion that guinea pig complement is inferior to rabbit com-
plement in its ability to lyse sensitized mouse lymphoid cells. 
The titrations of H-2.8 and H-2.13 demonstrate that, with cer-
tain sera, no activity at all is in fact found. Moreover, the 
difference between the two complements extends to hetero-antisera. 
These comments of course apply only to the antisera we used. They 
were hyperimmune sera, all shown to be insensitive to 2-mercapto-
ethanol. Such sera are believed to contain only IgG antibodies. 
As we pointed out, this is an important fact; for studies by Winn 
(1965) demonstrate that guinea pig complement can become even 
more efficient than rabbit complement if IgM antibodies are used 
as sensitizing agents. 
There are several possible explanations of the decreased 
efficiency of guinea pig complement, namely: 
- higher anticomplementary effects of mouse serum against guinea 
pig complement than against rabbit complement; 
- decreased concentration of one or several of the complement 
components in guinea pig complement; 
- a different mode of action of guinea pig complement, 
Anticomplementary effects 
Winn (1965) demonstrated that mouse serum can have a marked 
inhibitory effect on guinea pig complement. Sell (1964) has shown 
that the inhibition may be due to a complement-fixing antigen-
antibody reaction between mouse serum and guinea pig serum. In 
our experiments, these factors played a decisive role when we 
tested the relatively weak antisera H-2.8 and H-2.13 (table IV 
and fig. 4). In both cases two stage tests showed an increase of 
activity with guinea pig complement. Even if anticomplementary 
effects were diminished by using a two stage test, however, the 
two complements continued to differ in efficiency. In the tests 
of the stronger sera (fig. 3), anticomplementary effects were 
not likely to influence the cytotoxic activity, for we demonstra-
ted that these factors were of importance only in the first three 
or four dilutions of serum. The cytotoxic activity of these sera 
was calculated from the descending part of the titration curve 
A2 
at higher dilutions. With antiserum H-2.31 we demonstrated, 
moreover, that the cytotoxic activity with both complements 
failed to rise in the two stage test. It is evident, there-
fore, that the difference in activity between the two types 
of complement cannot be explained on the basis of anticomple-
mentary factors. 
Decreased concentration of complement components 
Evidently, a low concentration of a certain complement 
component might account for the decreased efficiency of guinea 
pig complement. However, Winn (1965) demonstrated that guinea 
pig complement can act very efficiently in a haemolytic sys-
tem if cells are sensitized with IgM antibodies. It will be 
demonstrated in the next chapter, moreover, that guinea pig 
complement can become as active as rabbit complement in the 
presence of excess IgG antibody, as long as anticomplementary 
factors are ruled out. These findings strongly suggest that 
all components are intact in guinea pig complement. 
Different mode of action 
Haughton et al. (1969) suggested that the difference in effi-
ciency between the two complements is probably due to the fact 
that, in the presence of IgG antibodies, guinea pig complement 
requires two reactive sites on the cell surface to be activated 
whereas rabbit complement needs only one. However, another re-
quirement to be met before guinea pig complement can be acti-
vated is related to the geometry of the reactive sites. Even 
if there are many such sites, unless they are sufficiently close 
together on the cell surface, guinea pig complement is unable to 
act. In an antibody titration, cells are sensitized with decrea-
sing amounts of antibody. At a certain antiserum dilution, a 
stage is reached in which not all antigenic sites on the cell 
are covered by the corresponding antibody; that is to say: there 
is no longer an antibody excess. If guinea pig complement re-
quires twice as many sites as rabbit complement, the difference 
in efficiency is bound to become manifest as the antiserum is 
diluted further. It could be argued that this difference is not 
to be expected when hetero-antisera are used, because these con-
tain many specificities and the concentration of reactive sites 
on the cell should therefore be higher than with monospecific 
antisera. This, however, is a misconception. One would expect 
to observe this phenomenon with all sera containing IgG anti-
bodies, even if they are polyspecific. A serum containing many 
specificities likewise attains a dilution, in the titration, at 
which antibody excess no longer exists. Upon further dilution, 
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more and more antigenic sites remain uncovered, and a different 
activity of guinea pig complement is to be expected. Our experi-
ments in fact confirmed this: a hetero-antiserum containing mouse-
specific and strain-specific antibodies, showed the phenomenon 
just as monospecific allo-antisera did. 
Although on theoretical grounds one might expect a lower effi-
ciency of guinea pig complement with each antiserum used, as long 
as it contains no IgM antibodies, there may be quantitative varia-
tions which depend on the amount and characteristics of the speci-
ficities contained in the serum. The antigenic sites of two diffe-
rent specificities could be localized so close together that, when 
both are sensitized, an antigen-antibody complex forms which can 
activate guinea pig complement. A cell not lysed by sensitization 
with one specificity, will be destroyed if a mixture of the two 
specificities is used. As we discussed in the previous chapter, 
the literature on this point is confusing. Synergistic effects 
have been described both with guinea pig and with rabbit comple-
ment, whereas other studies have demonstrated a blocking effect 
with both types of complement. 
For comparison of the separate sera with the antiserum mix-
tures in our tests, we calculated a hypothetical value which we 
call "the maximal expected cytotoxic activity". In view of the 
abovementioned findings, the use of this value calls for some 
elucidation. 
If two sera are mixed in equal volumes, each separate serum 
is diluted twice: this means that the cytotoxic activity of each 
serum diminishes by a factor 2 if in the mixture either serum 
acts independently. The maximal cytotoxic activity attained in 
the mixture must therefore be the sum of the activities of the 
separate sera, divided by two. In this case the sera have a 
purely additive effect. Should there be synergistic effects, 
however, then the activity measured should be higher than the 
maximal expected value. Should it be lower, then this would 
mean some negative interference, possibly due to blocking ef-
fects. 
The results of our experiments show a predominance of block-
ing effects in the tests with rabbit complement (table V). This 
would seem to warrant the conclusion that the antigenic sites 
involved are localized so close together that steric hindrance 
by antibody of different specifities plays a role. If this is 
true, one might expect synergistic effect with guinea pig com-
plement; but no such effects were observed. In only one instance 
(4 + 3,28) was the value found just significantly higher than 
that calculated. An attempt to explain these conflicting results 
will be made in chapter 8. 
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Not only was it demonstrated that most allo-antibody mix­
tures showed no synergistic effects, but in a different approach 
it was made clear that the specificities present in a hetero-anti-
serum did not act synergistically either. The ratio RC/GPC, which 
is a measure of the relative efficiency of the two complements, 
did not change after absorption of the hetero-antiserum with 
(ΒΙΟ χ A)F] lymphoid cells. As mentioned, it was shown that hetero-
antisera may contain H-2 specificities. These H-2 antibodies be­
come apparent when mouse species specificities are removed by 
suitable absorption (Sachs et al. 1971). The hetero-antiserum 
left after absorption contained only antibody H-2.31. Guinea pig 
complement and rabbit complement had the same relative efficiency 
with this serum as with the unabsorbed antiserum. 
The most plausible conclusion which emerges from these re­
sults is that the reactive sites of the specificities involved 
do not influence each other. For, if blocking influences were 
present with rabbit complement, the relative efficiency of this 
complement in the absorbed serum could be expected to increase. 
If synergistic effects were present in the titrations with guinea 
pig complement, on the other hand, the relative efficiency of 
this complement ought to diminish after absorption. Both pheno­
mena should lead to an increased RC/GPC ratio in the absorbed 
serum. The absence of such an increase constitutes a strong ar­
gument in favour of the assumption that the antigenic sites in 
question are localized so far apart that a reciprocal influence 
is ruled out. 
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C H A P T E R 7 
COMPLEMENT TITRATIONS 
Introduction 
Complement has been studied most extensively in a standard 
haemolytic system in which two factors - cell surface antigens 
and antibody - are kept constant, the variable being complement 
which is tested in serial dilutions. For this purpose, use is 
made of a standard amount of sheep red blood cells sensitized 
with excess rabbit anti-sheep red cell antibody (amboceptor). 
After addition of complement the amount of lysis can be easily 
measured by the release of haemoglobin. 
It has been shown that guinea pig complement can act very 
efficiently in this system, whereas rabbit complement is less 
efficient. We have mentioned studies by Winn (1965), who demon-
strated that this difference is related to the molecular class 
of antibody used. Guinea pig complement is readily activated 
by antibodies of high molecular weight (IgM), while rabbit com-
plement is more efficient when activated with antibodies of low 
molecular weight (IgG). The rabbit anti-sheep haemolysin common-
ly used in these tests, contains predominantly IgM antibodies 
(Paie 1939). 
It seemed of interest to study these events in an allogeneic 
system, particularly because we have shown in the previous chap-
ter that, in such a system, guinea pig complement is less effec-
tive than rabbit complement in the antibody titrations. In com-
plement titration studies with mouse erythrocytes and allo-anti-
sera, Winn (1965) demonstrated that guinea pig complement becomes 
at least as effective as rabbit complement if tested in antibody 
excess. However, when smaller amounts of antibody were used, rab-
bit complement was more efficient than guinea pig complement. 
These findings lend strong support to the theory that the num-
ber of reactive sites is of critical importance for the efficien-
cy of guinea pig complement. 
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Haughton (1969) studied the lysis of mouse lymph-node cells 
sensitized with excess allo-antiserum and found that guinea pig 
complement was less efficient than rabbit complement. However, 
anticomplementary effects were not excluded in his assay because a 
one stage method was used (Haughton 1970). 
In re-studying this problem, we have attempted to eliminate 
all factors impeding interpretation of results as best we could. 
To begin with, we used antisera containing only IgG antibodies. 
Secondly, all tests in which only slightly diluted antisera were 
used, were carried out in a two stage procedure in order to eli­
minate the anticomplementary effects of the sera. 
Complement titrations 
The two allo-antisera H-2.31 and H-2.3,28 were used in these 
titrations. They were tested separately and in a mixture of equal 
volumes. Moreover, both complements were tested after sensitiza­
tion of the cells with excess hetero-antiserum. Whenever anticom­
plementary effects due to relatively undiluted wera could be ex­
pected, two stage procedures were used. An amount of cells (50 yl 
= 5 χ lO^cells) was sensitized during 15 minutes at 40C with 
antibody (50 yl) of a given dilution, and centrifuged. The super-
natants were removed and different dilutions of complement (50 yl) 
and Hank's BSS (100 yl) were added for incubation during 30 minutes 
at 370C. Subsequent steps were the same as in the antiserum titra­
tions. The results of each test were again plotted on log probit 
paper, and a line of best fit was drawn. One unit of complement 
was defined as the amount which lyses half the cells or, in other 
words, gives 50% lysis. This unit is therefore written C5Q. The 
activity is expressed in units per ml. The following illustrates 
the actual calculation. 
Complement gives 50% lysis, say, at a dilution of 1/10. A 
1/10 dilution therefore represents one C50 unit. The undi­
luted sample thus contains 10 C50 units. Since 50 yl com­
plement is used in the test, the complement activity should 
'
n
-•-•_ = 200 C50 units per ml. 
The allo-antisera were first tested in two different dilu­
tions: I/I6 and 1/64. A one stage method was used because in view 
of our experience with antibody titrations of these sera (fig. 3), 
no anticomplementary effects were expected at these dilutions. 
The results of these titrations are presented in fig. 8. The com­
plement activity was calculated from these curves (table VII). It 
is evident that guinea pig complement was less active than rabbit 
complement at a serum dilution of 1/16. 
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Figure 8: Effects of two complement preparations on the 
cytolysis of L1210 cells. Complement titrations 
with allo-antisera. 
At the higher dilution (1/64), the activity of rabbit complement 
remained unchanged whereas that of guinea pig complement diminished 
to very low levels. An unmistakable diminution of the efficiency 
of guinea pig complement thus occurred when a limited antibody 
system was used. It seemed of interest to establish whether the 
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TABLE VII: EFFECTS OF TWO COMPLEMENT PREPARATIONS ON THE CYTOLYSIS OF 
H210 CELLS. COMPLEMENT ACTIVITIES AFTER SENSITIZATION WITH 
ALLO-ANTISERA AND WITH AN ANTISERUM MIXTURE 
Specificities Antiserum dilution Complement activity 
Rabbit С Guinea Pig С 
(C 5 0 U/ml) (C 5 0 U/ml) 
31 
3.28 
31 + 3 28 
1/16 
1/64 
1/16 
1/64 
1/16 
1/64 
640 
620 
44U 
420 
430 
400 
400 
<160 
340 
<160 
340 
<160 
activity of guinea pig complement would increase to a level 
comparable with that of rabbit complement if larger amounts 
of antibody were used to sensitize the cells. One of the anti-
sera (H-2.31) was therefore used in a 1/4 dilution. A two 
stage procedure was used this time because this serum could 
be expected to show marked anticomplementary effects. The out­
come of this titration is shown in fig. 9, which reveals that 
the maximal release remained below that with rabbit complement. 
% lysis 
30 40 50 
complement (діі) 
dilution 1 β 
Figure 9: Effects of two complement preparations on the 
cytolysis of L12I0 cells. Complement titrations 
with excess antibody H-2.31 (dilution 1:4) (two 
stage test). 
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This finding is in agreement with the results of the antibody 
titrations, which likewise disclosed a submaximal release with 
guinea pig complement. At lower complement concentrations, how­
ever, the efficiency of guinea pig complement equalled that of 
rabbit complement. In no case was guinea pig complement found 
to be more efficient than rabbit complement (as it is in the 
haemolytic system with sheep red cells and rabbit antibody). 
It has been shown in the chapter on antibody titrations 
that a hetero-antiserum behaved in the same way as the allo-
antisera. At higher antibody dilutions, guinea pig complement 
was less efficient than rabbit complement (fig. 6). The only 
difference from the titrations of allo-antisera was that with 
the hetero-antiserum the same maximal lysis was achieved for 
both complements. 
As we mentioned before, guinea pig complement is much more 
efficient than rabbit complement if tested with excess hetero-
antiserum containing mainly IgM antibodies, i.e. in the haemo­
lytic system with sheep red cells and rabbit antibody. What if 
guinea pig complement were tested in a similar system but with 
excess antiserum containing only IgG antibodies? The result of 
such a titration is presented in fig. 10. Unabsorbed rat anti-
B10.D2 serum was used as sensitizing agent. 
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Figure 10: Effects of two complement p r e p a r a t i o n s on the 
c y t o l y s i s of L1210 c e l l s . Complement t i t rat ion» 
with excess he tero-ant i serum (rat a n t i B10.D2 
serum, d i lut ion 1:16) (two stage t e s t ) . 
The 1/16 dilution supplied excess antibody. Both complements had 
a similar activity, and in this case guinea pig complement gave 
a maximal release as predicted from our findings in the antibody 
titration study. 
s 
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Discussion 
The results of the complement titration study furnish addi-
tional evidence that it is not a decrease in the concentration 
of complement components that causes the lower efficiency of 
guinea pig complement. The efficiency is much more likely to be 
correlated with the concentration of reactive sites on the cell 
surface. The two complements are equally efficient in antibody 
excess. In a limited antibody system (1/64 dilution), the acti-
vity of guinea pig complement is already diminished to very low 
levels while that of rabbit complement is still unchanged. 
Our tests with allo-antisera gave results which were in 
contrast to the findings reported by Haughton et al. (1969). 
They showed that guinea pig complement was about three times 
less efficient than rabbit complement when tested with excess 
allo-antibody. In our preliminary experiments we found that 
mouse serum can have marked inhibitory effects on these reac-
tions. The lower activity found by Haughton was most likely 
caused by anticomplementary effects because he did not use 
the two stage procedure. 
Some of the results described by Winn (1965) suggest that 
guinea pig complement can become even more efficient than rab-
bit complement if tested with excess allo-antibody and mouse 
erythrocytes. In our study, in which we used antisera contain-
ing only IgG, we never observed a higher efficiency of guinea 
pig complement. Perhaps Winn's serum contained small amounts 
of IgM antibodies, which might be responsible for his findings. 
We were also unable to demonstrate a higher activity of guinea 
pig complement when we tested a hetero-antiserum also contain-
ing no IgM antibody. This supports Winn's assumption that the 
high efficiency of guinea pig complement in the haemolytic sys-
tem may be ascribed to the predominance of IgM antibodies in 
this system. 
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C H A P T E R 8 
CONCLUSIONS 
The results of our study tend to corroborate reports by 
other investigators (Boyse et al. 1962, Winn 1965, Haughton 
et al. 1969) stating that there can be substantial differences 
in complement activity between sera from different species. This 
is of importance inasmuch as we have demonstrated that it can 
sometimes lead to false negative results in the cytotoxic test. 
It is probable that, to be activated, guinea pig complement re-
quires two reactive sites of IgG. Why this is so has not been 
established, but the best explanation so far seems to be that 
it must be related to some property of that complement component 
that actually binds with the antibody, i.e. Clq. The actual 
mechanism of action, however, remains obscure. 
In our experiments with allo-antiserum mixtures we found 
blocking effects of H-2 specificities in the presence of rabbit 
complement (table V). This suggests that the antigenic determi-
nants involved are localized very close together on the cell 
membrane. In view of these findings, we expected to be able to 
demonstrate synergism between H-2 specificities with guinea pig 
complement. This, however, proved generally not to be the case. 
The best explanation for these apparently conflicting results 
would seem to be that, with guinea pig complement, synergism 
as well as inhibition occurs. This is elucidated in fig. 11, in 
which antigen a and antigen b are localized so close together 
that competition can occur in the binding of antibodies of spe-
cificity a and specificity b. This means that, with antibody 
mixtures and rabbit complement, blocking effects are found. As-
suming guinea pig complement to be capable of bridging a distance 
of, say, four reactive sites, the course of the activation can be 
conceived of as follows. Upon addition of only antibody a, two 
reactive sites occur which are sufficiently close together to 
activate guinea pig complement (instance A). The same applies 
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Figure II: Schematic representation of the action of guinea 
pig complement in the presence of monospecific 
antisera separately (A and B) and of an anti­
serum mixture (C). 
to antibody b (instance B). Upon addition of a mixture of a and 
b antibodies, two of the four available antigenic sites are not 
sensitized due to steric inhibition. Guinea pig complement will 
nevertheless be activated because it is still just capable of 
bridging the distance between the two farther spaced reactive 
sites (instance C). The ultimate result will be that no differ­
ence occurs between activation with the separate antisera and 
that with the mixture. This means that only an additive effect 
will be observed. But this applies only of the two antigenic de­
terminants a and b are available in equal concentration. If the 
antigenic determinants are present on the cell membrane in un­
equal concentrations, it is quite conceivable that synergistic 
or blocking effects can nevertheless sometimes be predominant 
in the presence of guinea pig complement. 
The above conception is probably an extreme simplification 
of the true events. But it affords a plausible explanation of 
the results observed, which can be suumarized as follows. In 
the presence of rabbit complement, blocking effects are invari­
ably observed if the antigenic sites are sufficiently close to­
gether to cause steric hindrance. If the same specificities are 
tested with guinea pig complement, one may expect additive»syner­
gistic or blocking effects, dependent on the concentration of 
the various determinants. Conclusions on the spacing of the 
various determinants may therefore be drawn only from the results 
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obtained with rabbit complement. Since we observed blocking ef­
fects in nearly all instances with rabbit complement, we must 
assume that the H-2 antigens studied are localized close to­
gether on the cell membrane. 
Boyse (1968) demonstrated that an H-2 antibody which reacts 
specifically with a D end antigen, can inhibit the absorption of 
an anti D end antibody of different specificity (blocking effect). 
However, the absorption of an anti К end antibody was not in­
fluenced by an already absorbed anti D end antibody. He conclu­
ded from these facts that D end and К end antigens are not loca­
lized close together on the cell membrane. Our results fail to 
confirm this. In a combination of antibody H-2.31 (anti К end) 
and antibody H-2.4 (anti D end), an unmistakable blocking effect 
was observed (table V). It is difficult to form any conclusion 
concerning the blocking effect of anti H-2.31 and anti H-2.3,28, 
because there are indications that antigen 3 can be present as 
а К end as well as a D end antigen (Shreff1er 1971). 
On the other hand, the absence of blocking or synergism in 
the titration with hetero-antiserum (table VI) suggests that H-2 
antigens and mouse species antigens are localized farther apart. 
This implies that the antigens are not evenly distributed over 
the cell surface but occur in "clusters". Winn inferred the same 
hypothesis from his studies of complement fixation on mouse lymph-
node and thymus cells (Winn 1962). The hypothesis is also quite 
consistent with the immunohistochemical studies of Cerottini and 
Brunner (1967), who demonstrated by means of a semi-quantitative 
immunofluorescent technique that H-2 antigens are localized in 
discrete areas on the cell surface. 
We must therefore assume that clusters of allo-antigens 
and clusters of mouse species antigens occur. Moreover, the fact 
that blocking effects occur between the allo-antisera tested 
warrants the conclusion that the allo-antigenic clusters are 
made up of antigens of different specificity. Finally, our obser­
vations failed to show that D end and К end antigens occur in 
separate clusters, as Boyse et al. (1968) suggested. We could 
demonstrate blocking effects between these antigens. This obser­
vation shows that D end and К end antigens can occur in the same 
cluster of antigenic determinants. 
A submaximal release of -"'Cr in the presence of guinea pig 
complement and excess antibody was found in all titrations with 
allo-antisera (figs. 3 and 5). The unabsorbed hetero-antiserum, 
however, showed a virtually equal maximal release with both types 
of complement (fig. 6). Similar effects were observed in the com­
plement titrations with allo-antisera and hetero-antiserum (figs. 
8, 9 and 10). Since these findings cannot be explained by the 
influence of anticomplementary effects, it seems a plausible spe-
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culation that it might be related to the concentration of reac­
tive sites on the cell surface. Studies by Winn (1962) demonstra­
ted that the concentration of an antigenic specificity on the 
cell surface is not the same for each cell within a given popu­
lation. Some cells show a high concentration of antigenic deter­
minants, whereas other cells have only a few reactive sites on 
their surfaces. Assuming that this also applies to LI 210 cells, 
especially as these cells have not been synchronized and are at 
different stages of division, we may expect the various concen­
trations to be distributed in accordance with a β distribution' 
between minimum and maximum concentration. This situation is 
shown in fig. 12. 
number of cells 
I 
1
 threshold value 
* 
'Л η 
/ \ ' > 
¡ \ ι \ 
г  ' '
/4 Y 
1 
I 
Í 
1 
! \ \ \ 
ч 1 
\ 1 
min min max max 
concentration of antigenic sites 
Figure 12: Hypothetical 8-distribution of antigenic deter­
minants within a cell population, directed against 
one H-2 specificty ( ) or against multiple 
specificities of the hetero-antiserum ( ) 
Cells within shaded area have too low a concentra­
tion of antigenic sites and will be completely 
resistant to lysis in the presence of guinea pig 
complement. 
min. • minimum concentration. 
max. » maximum concentration. 
Sensitization with an excess of a monospecific antiserum might 
lead to such a low concentration of reactive sites on some cell 
surfaces that guinea pig complement cannot be activated, whereas 
rabbit complement is still able to lyse these cells because it 
T
 The β distribution for concentration с between its minimum 
(min) and its maximum (max) is characterized by the formula: 
constant χ (c - тіп)а (max - c)ß, 
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requires only half the reactive sites needed by guinea pig com-
plement. A certain percentage of the cells will therefore be 
resistant to guinea pig complement so that lysis is submaximal. 
But when the cells are sensitized with excess antiserum contain-
ing many specificities (e.g. a hetero-antiserum), the concentra-
tion of reactive sites on all cells will be sufficiently high 
to permit of their lysis by guinea pig complement. This hypo-
thesis can explain our findings, on maximal release (figs. 3 and 
5). We made no study of the effects of larger amounts of comple-
ment in this situation, but the aforementioned experiments by 
Winn suggest that, even with large amounts of complement, some 
cells will remain resistant to lysis (Winn 1962). 
The role of complement in graft rejection has not been 
elucidated. Some reports in the literature suggest that comple-
ment can be as active in cell destruction as it is in cytotoxic 
assays in vitro. When cells are incubated with specific anti-
body in vitro, they remain viable until complement is added. 
But when cells sensitized with antibody are injected into com-
patible animals, they are rapidly destroyed. Winn (1960b) de-
monstrated this with inoculates of 6C3HED lymphoma cells sen-
sitized with C57B1/6 anti 6C3HED serum. The tumours failed to 
grow in C3H mice unless large amounts of cells were used. Winn 
concluded that the isogeneic host provided the complement to 
destroy the sensitized cells. In addition he demonstrated that, 
even with inoculates of large numbers of cells, growth could 
be prevented by pre-treating the animals with guinea pig com-
plement. At least in these studies, the in vivo effect of com-
plement was comparable to its in vitro activity. 
There are several reports on the role of complement in the 
rejection of kidney grafts. Gewürz, Clark, Finstad, Kelly, Varco, 
Good and Gabrieson (1966) found a slight reduction of complement 
titre during renal graft rejection in dogs. Guiney, Austen and 
Russell (1964) demonstrated a pronounced diminution of the titre 
of the second complement component during renal allograft rejec-
tion in man. The whole complement titre did not significantly 
change in their study. The titre of the second component seems 
to be a more sensitive index of complement fixation in these 
cases, and this can be explained from our knowledge of comple-
ment activation. The decay of SAC 1,4,2 to stage SAC 1,4 is very 
rapid at 370C. New C2 molecules are used to rebuild a SAC 1,4,2 
complex, and in this cyclic process C2 is likely to be consumed 
during activation. The C2 titre consequently diminishes much 
more than the titres of the other С components or the whole 
complement titre. Radial immunodiffusion studies by Carpenter, 
Gell, Merrill and Daramin (1967) have demonstrated that the third 
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complement component also decreases during rejection in man. In 
a later study, moreover, investigators of this group demonstra-
ted hypercatabolism of C3 and C4 in patients with renal allo-
graft rejection (Carpenter, Ruddy, Shehadeh, Müller-Eberhard, 
Merrill and Austen 1969). 
All these findings suggest that complement can play a role 
in graft rejection. On the other hand, however, it has been 
demonstrated that mouse strains deficient in the fifth comple-
ment component reject skin allografts exactly as do mice without 
this deficiency (Caren and Rosenberg 1965), It seems possible, 
therefore, that not all complement components are required to 
destroy foreign cells in vivo. 
Thus, although there are unmistakable indications of in 
vivo processes comparable to in vitro events, it is by no means 
certain that results of in vitro studies can in fact be applied 
unchanged to the transplantation reaction. 
Nevertheless it seems probable that in vitro cytotoxic as-
says can give an understanding of the mechanism of the immune 
response. This applies in particular to the study of immunolo-
gical enhancement. As we mentioned, it is a prerequisite for 
achieving enhancement that the antisera used contain antibodies 
directed against all strong transplantation antigens which the 
graft introduces as foreign into the host. Otherwise, the unco-
vered antigens could lead to graft rejection. By designing a 
model in which the donor possesses two or three strong trans-
plantation antigens which the host does not possess, an attempt 
can be made to achieve an enhancing effect by immunizing the 
host with a mixture of serum containing antibodies directed 
against all these specificities. However, if there were syner-
gistic effects between these specificities in terms of cyto-
lysis, then the cytolytic effect on the graft in vivo could 
be expected to increase; and no enhancement would occur. Our 
in vitro results with the antiserum suggest no such synergism 
in the majority of instances. Our findings therefore warrant 
the expectation that enhancement can be achieved in vivo when 
serum mixtures are used in models comprising more than one anti-
genic difference. While clinical application of these principles 
may still seem far away, the results of studies of this kind are 
likely eventually to provide the tools for improved treatment of 
graft rejection in man. 
57 
Summary 
This study compares the activities of rabbit complement 
and guinea pig complement in terms of their ability to lyse 
L1210 tumour cells sensitized with antibody. Cytolysis was 
demonstrated by means of a 51cr release assay. Optimally mono-
specific H-2 allo-antisera and a rat anti-mouse lymphocyte 
serum were used as antibody. 
1. In the antiserum titrations, guinea pig complement was 
invariably less efficient than rabbit complement, in the 
titrations with allo-antisera as well as in those with 
the hetero-antiserum. 
2. The mouse sera used proved to contain strong anticomple-
mentary factors, which were most evident in the titrations 
with guinea pig complement. In some instances this even led 
to false negative results. However, the difference in effi-
ciency between the two types of complement was not explained 
by these factors, for after their elimination the guinea pig 
complement remained less active than rabbit complement. 
3. Data from the literature as well as the results of our own 
complement titration study make it unlikely that the differ-
ence in activity might be explained by a decreased concen-
tration of some complement component of guinea pig serum. 
The most plausible explanation would seem to be that, to be 
activated, guinea pig complement requires more reactive 
sites on the cell surface than rabbit complement. However, 
this applies only if IgG antibodies are used as sensitizing 
agents. 
4. When mixtures of monospecific H-2 antisera were titrated, 
blocking effects were found to occur in the presence of 
rabbit complement. This phenomenon indicates steric hin-
drance of antibody binding, and suggests that the antigenic 
determinants involved are localized very close together on 
the cell membrane. On theoretical grounds, synergistic ef-
fects might be expected with guinea pig complement in titra-
tions of combinations of allo-antisera. In most experiments, 
however, no such effects were observed. These seemingly con-
flicting results might be explained by the assumption that 
synergistic as well as inhibitory effects play a role in the 
titrations with guinea pig complement. 
5. Neither synergistic nor blocking effects were demonstrable 
between the species-specific and the strain-specific anti-
bodies present in the hetero-antiserum. This would seem to 
suggest that the distance between species-specific and strain-
specific antigenic sites on the cell membrane is so large that 
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a reciprocal influence is ruled out, 
6. The results obtained warrant the conclusion that the antigenic 
determinants lie on the cell surface in "clusters". The clus­
ters of allo-antigens are made up of determinants of different 
H-2 specificity. Moreover, the D end and К end antigens studied 
were found to occur together in the same clusters. 
7. All titrations in which allo-antisera were used with guinea 
ig complement, were characterized by submaximal release of 
^Cr. This phenomenon is probably due to the fact that a pro­
portion of the cell population is resistant to lysis as a re­
sult of an insufficient concentration of antigenic determi­
nants. Cells sensitized with a hetero-antiserum, however, have 
such a density of reactive sites on the surface that the pheno­
menon of submaximal release is not observed, 
8. When excess antibody was used in the complement titrations, 
the activity of guinea pig complement and that of rabbit com­
plement were on a comparable level. In a limited antibody sys­
tem, the activity of guinea pig complement was significantly 
diminished while that of rabbit complement remained unchanged. 
This is another argument in favour of the theory which explains 
the difference found between the two types of complement on the 
basis of the concentration of antigenic sites. 
9. The principal application of the results of this study in 
clinical transplantation is to be found in the phenomenon of 
immunological enhancement. In principle, it would seem to be 
possible to use mixtures of antisera in order to induce en­
hancement without increasing the risk of cytolysis, and there­
fore of graft rejection, by synergistic effects of the anti­
bodies used. 
! 
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Samenvatting 
In deze studie werden de activiteiten van konijnecomplement 
en caviacoraplement vergeleken met betrekking tot hun vermogen om 
met antilichaam gesensitizeerde LI210 tumorcellen te lyseren. De 
cytolysis werd aangetoond met behulp van een ^ 'Cr release assay. 
Als antilichaam werden zo goed mogelijk monospecifieke H-2 allo-
antisera en een rat anti-muis lymphocytenserum gebruikt. 
1. In de antiserum titraties bleek caviacomplement steeds minder 
effectief dan konijnecomplement. Dit gold zowel voor de titra-
ties met de allo-antisera, als voor die met het hetero-anti-
serum. 
2. De gebruikte muizensera bleken sterke anticomplementaire fac-
toren te bevatten, die vooral in de titraties met caviacom-
plement optraden. Dit leidde zelfs in enkele gevallen tot 
vals negatieve resultaten. Desondanks kon het verschil in 
effectiviteit tussen beide complementen hierdoor niet ver-
klaard worden. Immers, ook na eliminatie van de anticomple-
mentaire invloeden, bleef caviacomplement minder actief dan 
konijnecomplement. 
3. Zowel de literatuurgegevens als onze eigen resultaten met de 
complement titraties maken het onwaarschijnlijk dat het ver-
schil in activiteit verklaard kan worden uit een verminderde 
concentratie van een der componenten van caviacomplement. De 
meest plausibele verklaring is dat caviacomplement meer anti-
ge en- antilichaam complexen nodig heeft dan konijnecomplement 
om gesensitizeerd te worden. Dit geldt echter alleen, als IgG 
bevattende antisera gebruikt worden. 
4. Indien mengsels van mono-specifieke H-2 antisera getitreerd 
werden, bleken er in de aanwezigheid van konijnecomplement 
blokkerende effecten op te treden. Dit fenomeen wijst op ste-
rische inhibitie van de antilichaambinding en suggereert dat 
de betrokken antigene determinanten zeer dicht bijeen liggen 
op de celmembraan. Op theoretische gronden zou men met cavia-
complement synergistische effecten kunnen verwachten, in ti-
traties met combinaties van allo-antisera. Deze werden echter 
in de meeste experimenten niet waargenomen. Deze schijnbaar 
tegenstrijdige resultaten zou men kunnen verklaren door aan 
te nemen dat in de titraties met caviacomplement zowel syner-
gistische als blokkerende effecten een rol spelen. 
5. Er konden geen synergistische noch blokkerende effecten worden 
aangetoond tussen de species-specifieke en stam-specifieke 
antilichamen, die aanwezig waren in het hetero-antiserum. Dit 
pleit ervoor dat de afstand tussen species-specifieke en stam-
specif ieke antigenen op de celmembraan zó groot is, dat zij 
elkaar onderling niet kunnen beïnvloeden. 
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6. Uit de gevonden resultaten kan worden geconcludeerd dat de 
antigene determinanten in "trosjes" op het celoppervlak bij­
een liggen. De trosjes van allo-antigenen zijn opgebouwd uit 
determinanten van verschillende H-2 specificiteit. Bovendien 
is gebleken dat de onderzochte D end en К end antigenen samen 
in dezelfde trosjes voorkomen. 
7. In alle titraties, waarin allo-antisera tezamen met caviacom­
plement gebruikt werden, ontbrak een maximale release van 
Cr. Dit verschijnsel wordt waarschijnlijk veroorzaakt door­
dat een deel van de celpopulatie resistent is tegen lysis als 
gevolg van een te lage concentratie van antigene determinan­
ten. Als de cel daarentegen gesensitizeerd is met een hetero-
antiserum, dan is deze zo dicht bezet met antigeen-antilichaam 
complexen, dat er wel een maximale release optreedt. 
8. Indien in de complement titraties overmaat antilichaam werd 
gebruikt, dan was de activiteit van caviacomplement vergelijk­
baar met die van konijnecomplement, In een systeem met beperk­
te hoeveelheid antilichaam was er een significante daling van 
de activiteit van caviacomplement, terwijl de activiteit van 
konijnecomplement onveranderd bleef. Dit pleit opnieuw voor 
het belang van de concentratie van antigene determinanten ter 
verklaring van de gevonden verschillen tussen beide complemen­
ten. 
9. De belangrijkste toepassing van deze studie voor de klinische 
transplantatie wordt gevonden in het verschijnsel immunolo­
gische enhancement. Het lijkt in principe mogelijk om meng­
sels van antisera te gebruiken voor het induceren van enhance­
ment, zonder dat door synergistische effecten van de gebruik­
te antilichamen de kans op cellysis, en dus afstoting van het 
transplantaat, vergroot wordt. 
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S T E L L I N G E N 
Een vergelijking tussen de werking van cavia- en konijne-
complement is alleen mogelijk, als er rekening wordt ge-
houden met de klasse van de antilichamen die gebruikt 
worden. 
Dit proefschrift. 
Bij het opsporen van circulerende antilichamen in het 
serum van een potentiële ontvanger van een transplantaat 
door middel van een directe kruisproef is het gebruik 
van een "two stage" procedure onontbeerlijk. 
Dit proefschrift. 
Immunologische enhancement wordt niet veroorzaakt door een 
efferente blokkade van de immuunresponse. 
McKenzie, I.F.C., Koene, R., Winn, H.J. (1971) The 
mechanism of skin graft enhancement in the mouse. 
Transplant. Proc. ^ 3, 711. 
Het verdient overweging een nefrotisch syndroom door 
"minimal lesions" in eerste instantie te behandelen met 
cyclofosfamide, 
Moncrieff, M.W. , White, R.H.R. , Ogg, CS., Cameron, 
J.S. (1969) Cyclophosphamide therapy in the nephrotic 
syndrome in childhood. Brit. Med. J. I, 666, 
Wijdeveld, P.G.A.B. (]97\) Some clinical and thera-
peutic aspects of the nephrotic syndrome in the adult 
Folia Med. Neerl. U_, 4. 
Het is niet mogelijk om op basis van renale angiografie 
een onderscheid te maken tussen een acute rejectie en een 
recente acute tubulusnecrose in een niertransplantaat. 
Kaude, J. , Slusher, D.H., Pfaff, W.W., Hackett, R.L. 
(1970) Angiographie diagnosis of rejection and 
tubular necrosis in human kidney allografts. Acta 
Radiol. Diagn. 10, 476. 
De glucose infusietest volgens Cerasi en Luft geeft geen 
juiste indruk over de initiële insuline secretie. Deze 
bereikt haar hoogtepunt vóór het tijdstip, waarop in de 
test de eerste insulinebepaling wordt verricht, 
Cerasi, E., Luft, R. (1963) Plasma insulin response 
to sustained hyperglycaemia induced by glucose in-
fusions in human subjects. Lancet II, 1359. 
In tegenstelling tot vele literatuurgegevens is bij lijders 
aan terminale nierinsufficientie na intraveneuze glucose-
toediening niet alleen de late, maar ook de initiële insu-
line secretie sterk toegenomen. Hieruit blijkt dat de ge-
stoorde koolhydraattolerantie bij deze patiënten niet het 
gevolg is van een verminderde pancreasfunctie. 
Horton, E.S., Johnson, C., Lebovitz, H.E. (1968) 
Carbohydrate metabolism in uremia. Ann. Int. Med. 
68, 63. 
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liibulitie- en glucosuwaardeii in het ріаыі.а na ыюііс intra­
veneuze toediening van glucose bij 5 patiënten meJ uremie 
en bij 5 controlepersonen (Koene, R., van 't Laar, A.p 
Benraad, Th., de Nobel, E., onpepubliceerde waarnemingen). 
De opvatting van Berlyne e.a., dat tot 3 maanden na een 
niertransplantatie een omgekeerd dag- en nachtritme voor 
water en natrium bestaat, is niet algemeen geldig. 
Berlyne, G.M., Mallick, N.P., Seedat, Y.K., Edwards, 
E.G., Harris, R. , Orr, W.McN. (1968) Abnormal urinary 
rhythm after renal transplantation in man. Lancet II, 
435. 
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Normaal dng- en nachtritme voor water en natrium bij een 
patient na niertransplantatie. De waarneming werd begonnen 
in de zesde week na de transplantatie (Zijdeveld, P., van 
Lieber^en, F., Koene, R.f ongepubliceerde waarneming). 
9. Het onderzoeken en behandelen van grote aantallen patiënten 
vormt op zich geen waarborg voor het verkrijgen van de ver-
eiste vakkennis. 
10. De aesculaap op motorvoertuigen wordt vrijwel uitsluitend 
gebruikt als statussymbool, 



